| Literature DB >> 31057735 |
Vikram A Sarpe1, Michael G Pirrone1, Klara Haldimann2, Sven N Hobbie2, Andrea Vasella3, David Crich1.
Abstract
We describe a straightforward synthesis of the apramycin biosynthetic precursor saccharocin from apramycin by regioselective partial azidation followed by stereoretentive oxidative deamination. Saccharocin was found to exhibit excellent selectivity for inhibition of the bacterial ribosome over the eukaryotic ribosomes indicating that its presence as a minor impurity in apramycin itself should not be problematic in the development of the latter as a clinical candidate.Entities:
Year: 2019 PMID: 31057735 PMCID: PMC6482888 DOI: 10.1039/c9md00093c
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597